Results 291 to 300 of about 307,949 (334)

An age-and sex-matched postoperative therapy should be required in thyroid papillary carcinoma. [PDF]

Front Endocrinol (Lausanne)
Yan C, Sun J, He X, Jia L.
europepmc   +1 more source

Table3_MiR-29b-3p Inhibits Migration and Invasion of Papillary Thyroid Carcinoma by Downregulating COL1A1 and COL5A1.xlsx

Congjun Wang (1267932), Ye Wang (41998), Zhao Fu (8505798), Weijia Huang (576455), Zhu Yu (8799116), Jiancheng Wang (518932), Kaitian Zheng (9607487), Siwen Zhang (542137), Shen Li (432920), Junqiang Chen (842552)   +9 more
openalex   +1 more source

Tumor‐Associated Macrophages as Therapeutic Targets: Deciphering Interaction Networks and Advancing Clinical Translation

MedComm, Volume 7, Issue 2, February 2026.
Tumor‐associated macrophages are the most abundant immune cells in the tumor microenvironment, driving malignant progression and treatment resistance. This review summarizes the protumor mechanisms of TAMs (including phagocytosis modulation, metabolic reprogramming, exosomal communication, and immune interactions), evaluates three major strategies ...
Wurihan Bao, Xiaojie Qu, Yiqi Wang, Dan Huang, Huiling Zhang, Mingyuan Dong, Han Sun, Zhaogang Yang, Xuefeng Li   +8 more
wiley   +1 more source

Thyroid papillary carcinoma combined with primary follicular lymphoma: a case report. [PDF]

Diagn Pathol
Xu T, Wu L, Ye H, Luo S, Wang J.
europepmc   +1 more source

Triple HER2 Blockade With Trastuzumab, Pertuzumab, and Pyrotinib Versus Dual HER2 Blockade in the Neoadjuvant Treatment of HER2‐Positive Breast Cancer: A Randomized, Phase II Study

MedComm, Volume 7, Issue 2, February 2026.
Triple HER2 blockade with trastuzumab, pertuzumab, and pyrotinib (TPPy) did not improve total pathological complete response (tpCR) rates or breast pathological complete response (bpCR) rates compared with dual blockade with trastuzumab and pertuzumab (TP), but was associated with greater grade ≥ 3 toxicity, particularly diarrhea.
Jiahui Huang, Haoyu Wang, Yiwei Tong, Jin Hong, Yifei Zhu, Weili Ren, Jing Yu, Haoting Shi, Weiqi Gao, Siji Zhu, Jiayi Wu, Ou Huang, Jing Li, Jianrong He, Weiguo Chen, Yafen Li, Kunwei Shen, Xiaosong Chen   +17 more
wiley   +1 more source

A Case of Breast Papillary Carcinoma in an Elderly Black Male Patient With Pathology, Ultrasound, and Mammogram Imaging Findings. [PDF]

Cureus
Kent T, Petty DR, Hanna M.
europepmc   +1 more source

Papillary renal cell carcinoma with high‐ABCC2 shows an immune‐evasive profile associated with favorable response to immunotherapy

The Journal of Pathology, Volume 268, Issue 2, Page 188-199, February 2026.
Abstract The use of immune checkpoint inhibitors is a promising therapeutic strategy for metastatic papillary renal cell carcinoma (PRCC); however, predictive biomarkers remain limited. PRCCs with high ABCC2 expression represent an aggressive subset frequently associated with metastasis.
Vincent Francis Castillo, Abraam Zakhary, Fabio Rotondo, Caterina Di Ciano‐Oliveira, Malek Hamdani, Emelyn Adona, Theodorus van der Kwast, Kiril Trpkov, Rola Saleeb   +8 more
wiley   +1 more source

Early Diagnosis of Papillary Carcinoma in a Thyroglossal Duct Cyst: A Multidisciplinary Approach and the Crucial Role of Fine-Needle Aspiration Cytology. [PDF]

Cureus
Colino M, Breda D, Sepodes B, Melo C, Barroso LA.   +4 more
europepmc   +1 more source

Encapsulated papillary carcinoma originating from the vulva anogenital mammary-like glands: a rare case report. [PDF]

AME Case Rep
Si J, Yi J, Shen Y.
europepmc   +1 more source

Case Report: Low-Risk HPV associated Verruco-Papillary squamous cell carcinoma of the cervix

Olivia Nicolais, Mackenzie Cummings, Tommy Buchanan   +2 more
openalex   +1 more source